Last 7 days
1.0%
Last 30 days
-1.4%
Last 90 days
5.9%
Trailing 12 Months
-20.9%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
CME | 67.2B | 5.0B | -1.37% | -20.87% | 24.96 | 13.38 | 7.03% | 2.07% |
ICE | 55.5B | 9.6B | -10.69% | -24.62% | 38.36 | 5.76 | 5.10% | -64.37% |
NDAQ | 26.1B | 6.2B | -12.89% | -69.27% | 23.21 | 4.19 | 5.78% | -5.22% |
TROW | 24.5B | 6.5B | -12.11% | -22.62% | 12.06 | 3.54 | -15.43% | -49.47% |
CBOE | 13.1B | 4.0B | -4.92% | 7.40% | 55.9 | 3.32 | 13.27% | -55.58% |
MID-CAP | ||||||||
IBKR | 7.9B | 2.7B | -12.10% | 23.15% | 4.31 | 2.95 | 95.77% | 12.59% |
SEIC | 7.5B | 2.0B | -12.37% | -3.86% | 15.68 | 3.75 | 3.79% | -13.01% |
SF | 6.2B | 4.6B | -17.08% | -14.81% | 9.36 | 1.35 | -3.98% | -19.72% |
SNEX | 1.9B | 64.7B | -11.71% | 27.62% | 8 | 0.03 | 35.87% | 74.73% |
SMALL-CAP | ||||||||
BGCP | 2.0B | 1.8B | 17.91% | 16.69% | 41.14 | 1.12 | 16.43% | -60.72% |
VIRT | 1.8B | 2.4B | -12.59% | -48.39% | 6.93 | 0.78 | -15.89% | -44.42% |
COWN | 1.1B | 1.5B | 0.39% | 32.10% | 14.3 | 0.71 | -27.22% | -74.14% |
AC | 816.3M | 10.3M | -0.68% | -10.61% | -15.36 | 79.32 | -29.47% | -152.67% |
WETF | 742.8M | 301.3M | 9.41% | -21.41% | 14.66 | 2.47 | -0.98% | 1.78% |
OPY | 445.7M | 1.1B | -15.80% | -8.69% | 13.78 | 0.4 | -20.31% | -79.65% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 1.2% | 5,019 | 4,959 | 4,841 | 4,783 | 4,690 |
Costs and Expenses | 1.2% | 2,004 | 1,980 | 1,987 | 2,004 | 2,045 |
EBITDA | -4.0% | 3,819 | 3,978 | 3,928 | 3,714 | - |
EBITDA Margin | -7.4% | 0.76* | 0.82* | 0.82* | 0.79* | - |
Earnings Before Taxes | -7.5% | 3,551 | 3,839 | 3,651 | - | - |
EBT Margin | -1.2% | 0.71* | 0.72* | 0.79* | 0.76* | 0.73* |
Interest Expenses | -0.1% | 133 | 133 | - | - | - |
Net Income | 0.5% | 2,691 | 2,678 | 2,925 | 2,773 | 2,636 |
Net Income Margin | -0.7% | 0.54* | 0.54* | 0.60* | 0.58* | 0.56* |
Free Cahsflow | 11.9% | 2,966 | 2,650 | 2,616 | 2,477 | 2,275 |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -2.4% | 174,176 | 178,432 | 176,671 | 205,918 | 196,780 |
Current Assets | -2.9% | 139,078 | 143,253 | 141,451 | 171,004 | 161,762 |
Cash Equivalents | 27.7% | 2,720 | 2,130 | 1,880 | 2,046 | 2,835 |
Net PPE | -2.1% | 456 | 466 | 482 | 494 | 505 |
Goodwill | 0.3% | 10,483 | 10,447 | 10,484 | 10,516 | 10,528 |
Liabilities | -1.9% | 147,297 | 150,181 | 148,670 | 178,181 | 169,381 |
Current Liabilities | -2.1% | 137,688 | 140,573 | 139,000 | 168,459 | 160,398 |
. Short Term Borrowings | 10.3% | 16.00 | 15.00 | - | - | 749 |
Shareholder's Equity | -4.9% | 26,879 | 28,251 | 28,002 | 27,737 | 27,399 |
Retained Earnings | -22.3% | 4,747 | 6,112 | 5,798 | 5,499 | 5,152 |
Additional Paid-In Capital | 0.1% | 22,262 | 22,235 | 22,232 | 22,206 | 22,190 |
Accumulated Depreciation | 1.2% | 1,111 | 1,097 | 1,071 | 1,039 | - |
Shares Outstanding | 0.0% | 359 | 359 | 359 | - | - |
Minority Interest | - | - | - | - | - | - |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | 11.4% | 3,056 | 2,743 | 2,717 | 2,599 | 2,402 |
Share Based Compensation | 8.9% | 84.00 | 77.00 | 74.00 | 74.00 | 75.00 |
Cashflow From Investing | -23.5% | -489 | -396 | -314 | 70.00 | 58.00 |
Cashflow From Financing | -133.0% | -25,381 | -10,895 | -4,506 | 42,731 | 69,909 |
Dividend Payments | 1.4% | 2,634 | 2,597 | 2,556 | 2,515 | 2,189 |
41.1%
9.2%
0%
Y-axis is the maximum loss one would have experienced if CME Group was unfortunately bought at previous high price.
15.4%
13.0%
4.6%
2.5%
FIve years rolling returns for CME Group.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | reduced | -32.91 | -279,598 | 524,402 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | reduced | -4.88 | -5,740,660 | 53,451,300 | 0.06% |
2023-03-06 | NORTH STAR ASSET MANAGEMENT INC | reduced | -1.51 | -75,915 | 1,098,080 | 0.07% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -22.32 | -6,880,000 | 19,324,000 | 0.10% |
2023-03-03 | TIAA, FSB | reduced | -1.12 | -46,488 | 714,512 | -% |
2023-03-02 | LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA | new | - | 58,856 | 58,856 | -% |
2023-03-01 | Lakewood Asset Management LLC | new | - | 40,000 | 40,000 | 0.03% |
2023-03-01 | Regal Investment Advisors LLC | added | 27.61 | 73,755 | 419,755 | 0.04% |
2023-02-28 | Voya Investment Management LLC | reduced | -2.11 | -13,984,400 | 183,989,000 | 0.26% |
2023-02-27 | Cravens & Co Advisors, LLC | new | - | 614,625 | 614,625 | 0.57% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 13, 2023 | capital world investors | 4.4% | 15,768,261 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 9.21% | 33,139,178 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.2% | 26,025,197 | SC 13G/A | |
Feb 11, 2022 | capital world investors | 9.3% | 33,473,618 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 8.72% | 31,356,965 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 6.7% | 24,162,418 | SC 13G/A | |
Feb 16, 2021 | capital world investors | 9.5% | 33,945,618 | SC 13G/A | |
Feb 10, 2021 | vanguard group inc | 7.86% | 28,231,615 | SC 13G/A | |
Jan 29, 2021 | blackrock inc. | 7.0% | 25,295,042 | SC 13G/A | |
Feb 14, 2020 | capital world investors | 10.0% | 35,842,471 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | - - | - - | - - | - - | - - |
Current Inflation | 61.39 -67.21% | 85.56 -54.30% | 111.66 -40.36% | 155.16 -17.12% | 208.82 11.54% |
Very High Inflation | - - | - - | - - | - - | - - |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 16, 2023 | DEF 14A | DEF 14A | |
Mar 16, 2023 | DEFA14A | DEFA14A | |
Mar 10, 2023 | 8-K | Current Report | |
Feb 28, 2023 | 8-K | Current Report | |
Feb 27, 2023 | 10-K | Annual Report | |
Feb 16, 2023 | 4 | Insider Trading | |
Feb 13, 2023 | SC 13G/A | Major Ownership Report | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report | |
Feb 08, 2023 | 8-K | Current Report | |
Feb 07, 2023 | 5 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-02-16 | Durkin Bryan T | gifted | - | - | -1,367 | - |
2023-01-18 | SHEPARD WILLIAM R | bought | 218,906 | 175 | 1,243 | - |
2023-01-18 | SHEPARD WILLIAM R | bought | 9,650 | 175 | 54.839 | - |
2022-12-31 | DUFFY TERRENCE A | sold (taxes) | -3,452,490 | 168 | -20,531 | chairman and ceo |
2022-12-28 | SHEPARD WILLIAM R | bought | 48,645 | 168 | 289 | - |
2022-12-28 | SHEPARD WILLIAM R | bought | 2,144 | 168 | 12.757 | - |
2022-12-15 | Tully Sean | acquired | 18,936 | 155 | 122 | sr md global hd rates & otc |
2022-12-02 | Tierney Robert J JR | bought | 264,825 | 176 | 1,500 | - |
2022-11-04 | SHEPARD WILLIAM R | bought | 8,269,640 | 170 | 48,645 | - |
2022-09-27 | SHEPARD WILLIAM R | acquired | 2,132 | 180 | 11.788 | - |
CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues | |||
Total Revenues | $ 5,019.4 | $ 4,689.7 | $ 4,883.6 |
Expenses | |||
Compensation and benefits | 753.1 | 837.0 | 856.5 |
Technology | 188.6 | 192.6 | 198.5 |
Professional fees and outside services | 137.4 | 151.7 | 191.3 |
Amortization of purchased intangibles | 227.7 | 237.6 | 311.2 |
Depreciation and amortization | 134.9 | 147.8 | 153.2 |
Licensing and other fee agreements | 320.0 | 236.9 | 244.9 |
Other | 241.8 | 240.9 | 290.6 |
Total Expenses | 2,003.5 | 2,044.5 | 2,246.2 |
Operating Income | 3,015.9 | 2,645.2 | 2,637.4 |
Non-Operating Income (Expense) | |||
Investment income | 2,198.4 | 306.9 | 182.7 |
Interest and other borrowing costs | (162.7) | (166.9) | (166.2) |
Equity in net earnings (losses) of unconsolidated subsidiaries | 301.1 | 245.8 | 190.6 |
Other income (expense) | (1,862.4) | 342.6 | (122.4) |
Total Non-Operating | 474.4 | 728.4 | 84.7 |
Income before Income Taxes | 3,490.3 | 3,373.6 | 2,722.1 |
Income tax provision | 799.3 | 736.7 | 615.7 |
Net income | 2,691.0 | 2,636.9 | 2,106.4 |
Net Income (Loss) Attributable to Noncontrolling Interest | 0.0 | 0.5 | 1.2 |
Net income attributable to CME Group | 2,691.0 | 2,636.4 | 2,105.2 |
Net Income Attributable to Common Shareholders of CME Group | $ 2,657.2 | $ 2,617.1 | $ 2,105.2 |
Earnings per Common Share Attributable to CME Group: | |||
Basic | $ 7.41 | $ 7.30 | $ 5.88 |
Diluted | $ 7.40 | $ 7.29 | $ 5.87 |
Weighted Average Number of Common Shares: | |||
Basic | 358,713 | 358,340 | 357,764 |
Diluted | 359,181 | 358,929 | 358,524 |
Clearing and Transaction Fees [Member] | |||
Revenues | |||
Total Revenues | $ 4,142.7 | $ 3,765.1 | $ 3,897.4 |
MarketData [Member] | |||
Revenues | |||
Total Revenues | 610.9 | 576.9 | 545.4 |
OtherRevenue [Member] | |||
Revenues | |||
Total Revenues | $ 265.8 | $ 347.7 | $ 440.8 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 | ||
---|---|---|---|---|
Assets | ||||
Cash and cash equivalents | $ 2,720.1 | $ 2,834.9 | ||
Marketable securities | 96.0 | 115.0 | ||
Accounts receivable, net of allowance | 483.2 | 434.5 | ||
Other current assets | 529.8 | 427.8 | ||
Performance bonds and guaranty fund contributions | 135,249.2 | 157,949.6 | ||
Total current assets | 139,078.3 | 161,761.8 | ||
Property, net of accumulated depreciation and amortization | 455.5 | 505.3 | ||
Intangible assets-trading products | [1] | 17,175.3 | 17,175.3 | |
Intangible assets—other, net | 3,269.7 | 3,532.0 | ||
Goodwill | 10,482.5 | 10,528.0 | ||
Other assets | 3,714.4 | 3,277.9 | ||
Total Assets | 174,175.7 | 196,780.3 | ||
Liabilities and Shareholders' Equity | ||||
Accounts payable | 121.4 | 48.8 | ||
Short-term debt | 16.0 | 749.4 | ||
Other current liabilities | 2,300.9 | 1,650.6 | ||
Performance bonds and guaranty fund contributions | 135,249.2 | 157,949.6 | ||
Total current liabilities | 137,687.5 | 160,398.4 | ||
Long-term debt | 3,422.4 | 2,695.7 | ||
Deferred Income Tax Liabilities, Net | 5,361.1 | 5,390.4 | ||
Other liabilities | 826.0 | 896.5 | ||
Total Liabilities | 147,297.0 | 169,381.0 | ||
Shareholders' Equity: | ||||
Preferred stock, $0.01 par value, 10,000 shares authorized, none issued or outstanding | 0.0 | 0.0 | ||
Additional paid-in capital | 22,261.6 | 22,190.3 | ||
Retained earnings | 4,746.8 | 5,151.9 | ||
Accumulated other comprehensive income (loss) | (133.3) | 53.5 | ||
Total CME Group Shareholders' Equity | 26,878.7 | 27,399.3 | ||
Total Liabilities and Shareholders' Equity | 174,175.7 | 196,780.3 | ||
Class A Common Stock (Shares) [Member] | ||||
Shareholders' Equity: | ||||
Common stock | 3.6 | 3.6 | ||
Class B Common Stock (Shares) [Member] | ||||
Shareholders' Equity: | ||||
Common stock | $ 0.0 | $ 0.0 | ||
|